MEDP Medpace Holdings, Inc.
Research report · from SEC EDGAR · close 2026-07-13
$530.19 -1.5%
$15.14B mkt cap
executive summary
Medpace Holdings, Inc. (MEDP) is a $15.14B company. Revenue is $2.53B (+20.0% y/y) at a 18% net margin. It is profitable. Our health score is B (80/100). No major red flags on file. Smart money is buying (1 Congress). It funds itself; low dilution risk.
Revenue (FY)
$2.53B
+20.0% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 2
Cash & ST investments
$652.7M
Operating cash flow
$713.2M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.